Sponsor

AB Science

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name AB Science appears in 14 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials14
Recruiting shown1
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

14 shown
Masitinib in Patients With Mild Alzheimer's DiseaseNCT05564169 · lead sponsor · 2026-06-01
NOT_YET_RECRUITING
Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple SclerosisNCT05441488 · lead sponsor · 2022-06-28
SUSPENDED
Masitinib in the Treatment of Patients With Severe Uncontrolled Asthma and Elevated Eosinophil LevelsNCT03771040 · lead sponsor · 2016-12-01
COMPLETED
Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate CancerNCT03761225 · lead sponsor · 2014-09-01
COMPLETED
Masitinib in Patients With Mild to Moderate Alzheimer's DiseaseNCT01872598 · lead sponsor · 2012-01-01
COMPLETED
Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple SclerosisNCT01433497 · lead sponsor · 2011-08-01
COMPLETED
Masitinib in Refractory Active Rheumatoid ArthritisNCT01410695 · lead sponsor · 2011-07-01
TERMINATED
Masitinib in Treatment of Patients With Severe Persistent Asthma Treated With Oral CorticosteroidsNCT01449162 · lead sponsor · 2011-01-01
COMPLETED
Masitinib in Combination With Methotrexate, in Treatment of Patients With Active Rheumatoid ArthritisNCT00913432 · lead sponsor · 2007-03-01
COMPLETED
Activity of Masitinib (AB1010) in Mild to Moderate Alzheimer's DiseaseNCT00976118 · lead sponsor · 2006-02-01
COMPLETED
Efficacy of Oral AB1010 in Adult Patients With Severe Persistent Corticosteroid Dependent AsthmaNCT00842270 · lead sponsor · 2006-01-01
COMPLETED
Masitinib in Primary Progressive Multiple Sclerosis or Relapse-free Secondary Progressive Multiple SclerosisNCT01450488 · lead sponsor · 2005-06-01
COMPLETED
Efficacy of Oral AB1010 in Adult Patients With Active Rheumatoid ArthritisNCT00831922 · lead sponsor · 2004-09-01
COMPLETED
Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.NCT06280755 · collaborator · 2024-03-01
RECRUITING

Sponsor roles

lead sponsor13
collaborator1
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.